Validity and Reliability of the Assessment Tool for Asthma (ATA) Questionnaire: the ATA Study.
Autor: | Gemicioğlu B; Department of Pulmonary Diseases, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey., Mungan D; Department of Pulmonary Diseases, Division of Allerrgy and Immunology, Ankara University School of Medicine, Ankara, Turkey., Bavbek S; Department of Pulmonary Diseases, Division of Allerrgy and Immunology, Ankara University School of Medicine, Ankara, Turkey., Yıldız F; Department of Pulmonary Diseases, Kocaeli University School of Medicine, Kocaeli, Turkey., Polatlı M; Department of Pulmonary Diseases, Adnan Menderes University School of Medicine, Aydın, Turkey., Naycı S; Department of Pulmonary Diseases, Mersin University School of Medicine, Mersin, Turkey., Erkekol FÖ; Ataturk Chest Diseases and Thoracic Surgery Education and Research Hospital, Ankara, Turkey., Türker H; Süreyyapasa Chest Diseases and Thoracic Surgery Education and Research Hospital, İstanbul, Turkey., Günen H; Süreyyapasa Chest Diseases and Thoracic Surgery Education and Research Hospital, İstanbul, Turkey., Çamsarı G; Yedikule Chest Diseases and Thoracic Surgery Education and Research Hospital, İstanbul, Turkey., Abadoğlu Ö; Department of Pulmonary Diseases, Cumhuriyet University School of Medicine, Sivas, Turkey., Çımrın A; Department of Pulmonary Diseases, Dokuz Eylül University School of Medicine, İzmir, Turkey., Dursun AB; Department of Internal Medicine, Division of Allergy and Immunology, Recep Tayip Erdoğan University School of Medicine, Rize, Turkey., Göksel Ö; Department of Pulmonary Diseases, Division of Allerrgy and Immunology, Ege University School of Medicine, İzmir, Turkey., Özdemir SK; Dışkapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey., Börekci Ş; Department of Pulmonary Diseases, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey., Aydın Ö; Department of Pulmonary Diseases, Division of Allerrgy and Immunology, Ankara University School of Medicine, Ankara, Turkey., Ocaklı B; Süreyyapasa Chest Diseases and Thoracic Surgery Education and Research Hospital, İstanbul, Turkey., Gür A; Yedikule Chest Diseases and Thoracic Surgery Education and Research Hospital, İstanbul, Turkey., Baygul A; Department of Biostatistics, Beykent University, İstanbul, Turkey., Mısırlıgil Z; Department of Pulmonary Diseases, Division of Allerrgy and Immunology, Ankara University School of Medicine, Ankara, Turkey. |
---|---|
Jazyk: | angličtina |
Zdroj: | Turkish thoracic journal [Turk Thorac J] 2020 Mar 01; Vol. 21 (2), pp. 93-99. Date of Electronic Publication: 2020 Mar 01 (Print Publication: 2020). |
DOI: | 10.5152/TurkThoracJ.2019.180186 |
Abstrakt: | Objectives: A multicenter trial was designed to validate the "Assessment Tools for Asthma (ATA)" questionnaire, a newly developed questionnaire, which evaluates both asthma control and risk factors associated with asthma control with a single instrument. Materials and Methods: This cross-sectional study involved 810 cases from 14 clinics in 9 Turkish cities. The ATA questionnaire and Asthma Control Test (ACT) were administered. The Visual Analog Scale (VAS) was used to evaluate the control status of 100 randomized cases. ATA is an eight-item physician-administered questionnaire. It comprises the following two sections-ATA1, assesses symptomatic control criteria, and the remaining section, queries the flare-up of asthma, control of comorbidities, treatment adherence, and inhaler technique. Results: The mean scores for ATA1, ATA total, VAS, and ACT were 24.7±14.8, 53.8±19, 7.1±3, and 18.8±5.5, respectively. According to the ATA questionnaire, among all patients, 34.3% had controlled, 18.8% had partly controlled, and 46.9% had uncontrolled asthma. Furthermore, 16.6% patients had flare-ups between visits, 96.4% patients had uncontrolled comorbidity, 17% patients had irregular asthma treatment, and only 8.4% patients used the incorrect inhaler technique. The ATA questionnaire showed internal consistency (Cronbach's alpha coefficient=0.683). ACT, ATA1, and two specialists' evaluations using VAS correlated strongly with the ATA total scores (Spearman correlation coefficient (r) values: 0.776, 0.783, and 0.909, respectively; p-values: p<0.001, p<0.001, and p<0.001, respectively). According to Receiver Operating Characteristic analysis, the cut-off value of ATA was 50 (sensitivity=84.4%, specificity=82.40%). Conclusion: The validated ATA questionnaire may be a practical tool for physicians in asthma management. |
Databáze: | MEDLINE |
Externí odkaz: |